Siemens Chek-Stix Control Strips Recalled for Potential Leukocyte Result Errors
Siemens Healthcare Diagnostics is recalling Chek-Stix Combo Pak control strips because the leukocyte result may become negative if the solution is held above 25°C for more than two hours.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issue is a potential inaccuracy in control results rather than a direct patient safety hazard like a device failure or contamination.
Plain-English summary
Siemens Healthcare Diagnostics Inc is recalling 16,711 units of Chek-Stix Combo Pak, Catalog Number 1364. These are positive and negative control strips used for urine chemistry testing. The product was distributed nationwide in the United States and internationally to Canada, Aruba, Brazil, Denmark, India, Mexico, New Zealand, Singapore, Thailand, the Bahamas, South Wales, and Hong Kong.
The recall is due to a potential issue with the leukocyte result. When the control material is reconstituted, the positive control solution leukocyte result may become negative if the solution is held for more than two hours above 25°C (77°F). This could lead to inaccurate quality control results for urinalysis testing.
Users of these control strips should stop using the affected lots and contact Siemens Healthcare Diagnostics for further instructions. The specific lot numbers affected are listed in the recall documentation.
The recalled product
- Product
- Siemens Chek-Stix Combo Pak Catalog Number: 1364 Chek-Stix¿ Positive and Negative Control Strips for Urine Chemistry: When used with Siemens reagent strips and tablets for urinalysis, CHEK-STIX¿ positive and negative control strips provide defined results for glucose, biliru
- Manufacturer
- Siemens Healthcare Diagnostics Inc
- Hazard
- Affected units
- 16,711
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Siemens Healthcare Diagnostics Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics Inc
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · inaccurate test result
See all →- ModerateTosoh ST AIA-Pack Testosterone Diagnostic Test Kit Recall
FDA (Devices) · 2026-07-22
- ModerateAbbott HbA1c Hemoglobin Afinion Test Kit Cold Chain Failure
FDA (Devices) · 2025-06-04
- HighFDA Recalls Multiple Unauthorized Diagnostic Test Products by Universal Meditech
FDA (Devices) · 2023-11-01
- HighSTA R Max Analyzer Firmware Bug Produces Inaccurate Coagulation Test Results
FDA (Devices) · 2023-05-17
- ModerateSiemens Total Bilirubin Reagent Cartridge Recall for Eltrombopag Interference
FDA (Devices) · 2020-04-01